Posted by on August 12, 2023 4:00 am
Tags:
Categories: c2g6

BIOATTACKS ANTICIPATED

Current Indicator Threat Grade
Grade No or UNKNOWN RISK

No or UNKNOWN RISK

No reports. No current evidence. Click FIELD REPORT to share with us a link or your first-hand account.

BIOATTACKS ANTICIPATED

The FutureDanger Indicator System contains nearly 500 predefined conditions or possible events. As our team fulfills it mission, check back soon for a thorough description of this one.
Background on this indicator will be provided here in the near future.
News relevant to this indicator that emerges from open sources may lead to threatening conditions for the American Nation. The team at FutureDanger will provide a clear explanation of these risks as soon as possible.
Credit
Developed by FutureDanger
Primary References
    None

Full Indicator Record

Indicator Historical Trend
1,1,1,1,1,1,1,1,1,1,1
Today
2017-03-19
Grade Date Headline Source
MOD 24 May 2020 DoD concerned China is seeking American service member DNA [Breitbart]
SEVERE 15 May 2020 Report: Chinese experimenting with bioweapons targeting ethnic groups [ Sara A. Carter]
SEVERE 23 Apr 2020 Pentagon and Intelligence Community Probe Threat of Coronavirus Bioweapon [Politico]
LOW 17 Oct 2018 Anthrax and Plague Vaccine Developed Amid Fears of Bioterrorism [UK Daily Mail]
LOW 20 Jun 2018 Synthetic biology raises risk of new bioweapons, report warns [UK Guardian]
LOW 13 Nov 2017 DHS preps for bioattack on infrastructure in Oklahoma [ZeroHedge]
MOD 23 Oct 2017 NKorea mass producing bioweapons... smallpox, cholera, plague and anthrax [UK Sun]
LOW 21 Jul 2017 Experts: Terrorists could weaponize deadly plague disease by releasing it as a cloud above cities killing thousands [UK Sun]
LOW 18 Apr 2017 NKorean agents to release bioweapons in major US cities? [TMIN]
MOD 25 Mar 2017 DoD prepping for synthetic biological threats – 'cheap, available and easy to transmit' [ Homeland Preparedness News]
LOW 19 Mar 2017 Federal Govt preparing to spend hundreds of millions for anthrax vaccine [Nasdaq]